Investigation of antiviral resistance and escape mutations in children with naive chronic hepatitis B patients and their parents
In this study, it was aimed to scan the resistance to nucleoside analogs innaive pediatric patients with chronic hepatitis B treatment and their parentsand the rate of accompanying possible escape mutations. A total of 34children who did not receive any treatment regarding chronic hepatitis B and19 parents who caused vertical transmission or acquired transmission fromfather were involved in the study. Serological tests concerning hepatitis Bvirus and transaminases in conjunction with viral load were studied. HBVgenotypes, subgenotypes were determined by surface gene sequencings. Thegene mutations coding polymerase (pol) for resistance against nucleosideanalogs and escape mutations in the genes coding surface (S) proteins wereanalyzed with PCR method. All cases were genotype D. Only one pediatricpatient was D2; the rest of all pediatric patients and their parents weregenotype D1. Resistance was not identified against nucleoside analogs inany children or their parents. HBsAg escape mutations determined in thechronic hepatitis B patients were 18.8% (10 case). It can be speculated withthis results that the resistance may not be considered as a problem in thepreference of nucleoside analogs in treatment of naive children. Nevertheless,escape mutations were seen as high in both children and parents as well. Sinceit interests public health on a large scale, advanced studies and evaluation ofvaccination escape mutations’ rate in broad case series and their follow upare of great importance in the determination of health policies with regardto hepatitis B infection control.
___
1. Trepo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet 2014; 384: 2053-2063.2. Tran TT, Martin P. Hepatitis B: epidemiology and natural history. Clin Liver Dis 2004; 8: 255-266.
3. Akhan S, Aynıoğlu A, Çağatay A, et al. Kronik Hepatit B virusu infeksiyonunun yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu. Klimik Dergisi 2014; 27(Özel Sayı 1): 2-18.
4. European Association for the Study of Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167- 185.
5. Locarnini S, Zoulim F. Molecular genetics of HBV infection. Antivir Ther 2010; 15: 3-14
6. Salpini R, Svicher V, Cento V, et al. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. Antiviral Res 2011; 92: 382-385.
7. Shaw T, Bartholomeusz A, Locarnini S. HBV drug resistance: mechanisms, detection and interpretation. J Hepatol 2006; 44: 593-606.
8. Margeridon-Thermet S, Shulman NS, Ahmed A, et al. Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reversetranscriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 2009; 199: 1275-1285.
9. Ergünay K, Kahramanoğlu Aksoy E, Simşek H, et al. Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases. Mikrobiyol Bul 2013; 47: 628-635.
10. Ciftci S, Keskin F, Cakiris A, et al. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method. Diagn Microbiol Infect Dis 2014; 79: 25-30.
11. Liu BM, Li T, Xu J, et al. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients. Antiviral Res 2010; 85: 512-519.
12. Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?. Bull World Health Organ 2010; 88: 66-73.
13. Sayan M, Buğdacı MS. HBV vaccine escape mutations in a chronic hepatitis B patient treated with nucleos(t) ide analogues. Mikrobiyol Bul 2013; 47: 544-549.
14. Komatsu H, Inui A, Fujisawa T. Pediatric hepatitis B treatment. Ann Transl Med 2017; 5: 37.
15. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004; 32 (Web Server issue) W654-W659.
16. Sayan M, Sentürk O, Akhan SÇ, Hülagü S, Cekmen MB. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis 2010; 14: e136-e141.
17. Avellon A, Echevarria JM. Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol 2006; 78: 24-36.
18. Sayan M, Cavdar C, Dogan C. Naturally occurring polymerase and surface gene variants of hepatitis B virus in Turkish hemodialysis patients with chronic hepatitis B. Jpn J Infect Dis 2012; 65: 495-501.
19. Zhao Y, Wu J, Sun L, et al. Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t) ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China. Braz J Infect Dis 2016; 20: 173-178.
20. Yildiz O, Aygen B, Demirtürk N, et al. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. World J Gastroenterol 2011; 17: 4987-4992.
21. Sayan M, Akhan SC, Meric M. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B. J Viral Hepat 2010; 17: 23-27.
22. Nguyen MH, Garcia RT, Trinh HN, et al. Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B. Aliment Pharmacol Ther 2009; 30: 1150-1158.
23. Keeffe EB, Dieterich DT, Han SHB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 2008; 6: 1315-1341.
24. Sayan M. Molecular diagnosis of entecavir resistance. Hepatitis Monthly 2010; 10: 42-47.
25. Sokal EM, Paganelli M, Wirth S, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines Consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Hepatol 2013; 59: 814-829.
26. Bozdayi AM, Aslan N, Bozdayi G, et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 2004; 149: 2115-2129.
27. Serin MS, Akkiz H, Abayli B, et al. Genotyping of hepatitis B virus isolated from chronic hepatitis B patients in the south of Turkey by DNA cyclesequencing method. Diagn Micr Infec Dis 2005; 53: 57-60.
28. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 2002; 25: 97- 106.
29. Mendy M, D’Mello F, Kanellos T, Oliver S, Whittle H, Howard CR. Envelope protein variability among HBV-infected asymptomatic carriers and immunized children with breakthrough infections. J Med Virol 2008; 80: 1537-1546.
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Treatment of severe leptospirosis with therapeutic plasma exchange in a pediatric patient
İlknur Tolunay, Özden Özgür Horoz, Derya Alabaz, Ercüment Petmezci, R. Dinçer Yıldızdaş, Faruk Ekinci
Çağlar ÖDEK, Tanıl KENDİRLİ, Nihan YILDIRIM YILDIZ, Ayhan YAMAN, Tayfun UÇAR, Zeynep EYİLETEN, CAN ATEŞ, Adnan UYSALEL, Ercan TUTAR, Semra ATALAY
Fever-induced Brugada syndrome in a 9-year-old boy presenting with acute chest pain
Gülser Esen BESLİ, SEMA YILDIRIM, İbrahim AKALIN, Yusuf İzzet AYHAN, Merve KİŞİOĞLU, Afig BERDELİ
Zeynep İNCE, Özgül BULUT, Melike TUĞRUL AKSAKAL, Ayşegül ÜNÜVAR, Ömer DEVECİOĞLU, Asuman ÇOBAN
Mustafa ÇAKAN, Nuray AKTAY AYAZ, Hakan GEMİCİ, Agageldi ANNAYEV, Agop ÇITAK, Arzu AKÇAY, Gülyüz ÖZTÜRK
Maria Teresa SANCHEZ AVILA, Oscar Alejandro GARCIA VALENCIA, Marian Rivas CALDERON, Luis Alonso MORALES GARZA, Perla Jacobo VELAZQUEZ, KARLA LORENA Chavez Caraza
Betül SÖZERİ, Bengü GERÇEKER TÜRK, Başak Yıldız ATIKAN, Sevgi MİR, Afig BERDELİ
Tugay TARTAR, Ayşe SAĞMAK TARTAR, Mehmet SARAÇ, Ünal BAKAL, Ayhan AKBULUT, Ahmet KAZEZ
A girl with Henoch Schönlein purpura associated with acute rheumatic fever and review of literature
Ebru AYPAR, Duygu DEMİRTAŞ, Hayrettin Hakan AYKAN, Fehime KARA EROĞLU, Ali DÜZOVA
Ultrasound guided percutaneous central venous catheters in neonatal intensive care unit
Ufuk ATEŞ, Turan DERME, Yavuz YILMAZ, Hülya Özkan ULU, Fuat Emre CANPOLAT